Antibody evasion by the P.1 strain of SARS-CoV-2

Dejnirattisai, Wanwisa; Zhou, Daming; Supasa, Piyada; Liu, Chang; J. Mentzer, Alexander; M. Ginn, Helen; Zhao, Yuguang; M. E. Duyvesteyn, Helen; Tuekprakhon, Aekkachai; Nutalai, Rungtiwa; Wang, Beibei; López‐Camacho, César; Slon-Campos, Jose; S. Walter, Thomas; Skelly, Donal; Ann Costa Clemens, Sue; Gomes Naveca, Felipe; Alves do Nascimento, Valdinete; Nascimento, Fernanda; Fernandes da Costa, Cristiano; Cristina Resende, Paola; Pauvolid‐Corrêa, Alex; Mendonça Siqueira, Marilda; Dold, Christina; H. Levin, Robert; Dong, Tao; J. Pollard, Andrew; C. Knight, Julian; W. Crook, Derrick; Lambe, Teresa; Clutterbuck, Elizabeth; Bibi, Sagida; Flaxman, Amy; Bittaye, Mustapha; Belij‐Rammerstorfer, Sandra; C. Gilbert, Sarah; W. Carroll, Miles; Klenerman, Paul; Barnes, Eleanor; Dunachie, Susanna; G. Paterson, Neil; A. Williams, Mark; R. Hall, David; J. G. Hulswit, Ruben; A. Bowden, Thomas; E. Fry, Elizabeth; Mongkolsapaya, Juthathip; Ren, Jingshan; I. Stuart, David; Screaton, Gavin

doi:10.1016/j.cell.2021.03.055

Public

Antibody evasion by the P.1 strain of SARS-CoV-2

Published in Cell • Mar 30, 2021

Authors:

Wanwisa Dejnirattisai

Daming Zhou

Piyada Supasa

Abstract

Terminating the SARS-CoV-2 pandemic relies upon pan-global vaccination. Current vaccines elicit neutralizing antibody responses to the virus spike derived from early isolates. However, new strains have emerged with multiple mutations, including P.1 from Brazil, B.1.351 from South Africa, and B.1.1.7...

Subject

Biology

Virology

Strain (injury)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!